Literature DB >> 23706613

HLA-B*57:01(+) abacavir-naive individuals have specific T cells but no patch test reactivity.

Benno Schnyder1, Jacqueline Adam1, Andri Rauch2, Maria C Thurnheer2, Werner J Pichler3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23706613     DOI： 10.1016/j.jaci.2013.04.013

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  7 in total

Review 1.  Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.

Authors:  Rebecca Pavlos; Simon Mallal; David Ostrov; Yuri Pompeu; Elizabeth Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2014 Jan-Feb

2.  Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing: 2014 update.

Authors:  M A Martin; J M Hoffman; R R Freimuth; T E Klein; B J Dong; M Pirmohamed; J K Hicks; M R Wilkinson; D W Haas; D L Kroetz
Journal:  Clin Pharmacol Ther       Date:  2014-02-21       Impact factor: 6.875

3.  Abacavir-reactive memory T cells are present in drug naïve individuals.

Authors:  Andrew Lucas; Michaela Lucas; Anette Strhyn; Niamh M Keane; Elizabeth McKinnon; Rebecca Pavlos; Ellen M Moran; Viola Meyer-Pannwitt; Silvana Gaudieri; Lloyd D'Orsogna; Spyros Kalams; David A Ostrov; Søren Buus; Bjoern Peters; Simon Mallal; Elizabeth Phillips
Journal:  PLoS One       Date:  2015-02-12       Impact factor: 3.240

4.  Risk Assessment in Drug Hypersensitivity: Detecting Small Molecules Which Outsmart the Immune System.

Authors:  Werner J Pichler; Stephen Watkins; Daniel Yerly
Journal:  Front Allergy       Date:  2022-02-22

Review 5.  Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response.

Authors:  Katie D White; Wen-Hung Chung; Shuen-Iu Hung; Simon Mallal; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol       Date:  2015-08       Impact factor: 10.793

Review 6.  Pathogenesis and diagnosis of delayed-type drug hypersensitivity reactions, from bedside to bench and back.

Authors:  Rik Schrijvers; Liesbeth Gilissen; Anca Mirela Chiriac; Pascal Demoly
Journal:  Clin Transl Allergy       Date:  2015-09-03       Impact factor: 5.871

Review 7.  The important role of non-covalent drug-protein interactions in drug hypersensitivity reactions.

Authors:  Werner J Pichler
Journal:  Allergy       Date:  2021-06-14       Impact factor: 14.710
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.